Because of this authorization, RJR will have to abide by strict marketing restrictions, including on digital, radio and television advertising. This is done to limit youth exposure to tobacco advertising for these products.
This authorization comes as the FDA has taken action on over 98 percent of the applications it received by the Sept. 9, 2020 deadline. MDOs have been issued for more than a million flavored ENDS products that the FDA determined to be lacking in sufficient evidence that showed that the benefit to adult smokers who used the flavored products would overcome the public health concern posed by the well-documented and considerable appeal of the products to youth [read more here].
You can read the full press release on Vuse’s FDA authorization by clicking here.
For all the latest news from the FDA, visit FDA.gov.